Expression of hypoxia inducible factor-1α and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof

National Medical Journal of China

Volumn 86, Issue 28, 2006, Pages 1970-1974

  Zhou, Jin Tang ^a   Cai, Zhi Ming ^b   Li, Ning Chen ^c   Na, Yan Qun ^c  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^c NONE

Author keywords

Bladder neoplasms; Glucose transporter protein 1 (Glut 1); Hypoxia inducible factor 1 (HIF 1 ); Kidney neoplasms

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; CARCINOMA, RENAL CELL; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 33748035048     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res,1998, 58:1408-1416.
2. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res, 1999,59:5830-5835.
3. Ebert BL, Firth JD, Ratcliffe PJ. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem, 1995,270:29083-29089.
4. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer, 1955,9:539-549.
5. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 2003, 3:721-732.
6. Talks KL, Turley H, Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol, 2000,157:411-421.
7. Theodoropoulos VE, Lazaris AC, Kastriotis I, et al. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma. BJU Int, 2005,95:425-431.
8. Theodoropoulos VE, Lazaris Ach, Sofras F,et al. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol, 2004,46:200-208.
9. Gnarra JR, Tory K, Weng Y, et al Mutation of the VHL tumour suppressor gene in renal carcinoma. Nat Genet, 1994,7:85-90.
10. Wiesener MS, Munchenhagen PM, Berger I, et al. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res,2001,61:5215-5222.
11. Turner KJ, Moore JW, Jones A, et al.. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res, 2002,62: 2957-2961.
12. Hoskin PJ, Sibtain A, Daley FM, Wilson GD. GLUT-1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vasculaity and proliferation as predictors of outcome of ARCON. Br J Cancer,2003,89:1290-1297.
13. Chang S, Lee S, Lee C, et al. Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder. Urology, 2000,55:448-452.
14. Younes M, Juarez D, Lechago LV, et al. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Anticancer Res,2001,21:575-578.
15. Palit V, Phillips RM, Puri R, et al. Expression of HIF-1alpha and Glut-1 in human bladder cancer. Oncol Rep,2005,14:909-913.
16. Nagase Y, Takata K, Moriyama N, et al. Immunohistochemical localization of glucose transporters in human renal cell carcinoma. J Urol,1995,153(3 Pt 1):798-801.